FACE IPF
HEAD ON
and modify disease progression by slowing lung function decline
![thumbnail-image](/mea/lb/sites/default/files/2023-08/media%402x.png)
PPF in CTD-ILD: How do we keep patients on treatment with nintedanib?
10/06/2024 | Author: Boehringer Ingelheim
PPF in CTD-ILD: How do we keep patients on treatment with nintedanib?
Document ID: PC-AE-102133 | Expiry Date: 08/05/2026